Showing results (71-80 of 108) with videos related to
Sort By:
Pageof 11
Blood|April 15, 1997
Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patientsA Scaradavou, B Woo, B M Woloski, et al.Hematology (Amsterdam, Netherlands)|July 27, 2007
Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpuraL M Aledort, A Salama, L Kovaleva, et al.Vox Sanguinis|January 1, 1994
Hepatitis A virus transmission by blood products in the United States. Transfusion Safety Study GroupJ W Mosley, M J Nowicki, C K Kasper, et al.Blood|April 1, 1994
Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study GroupP M Mannucci, D B Brettler, L M Aledort, et al.Journal of Thrombosis and Haemostasis : JTH|March 17, 2010
Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)T B Gernsheimer, J N George, L M Aledort, et al.European Journal of Pediatrics|April 1, 1994
Tracheostomy in childrenB Simma, D Spehler, R Burger, et al.Vox Sanguinis|June 11, 2014
A safe therapeutic apheresis protocol in paediatric patients weighing 11 to 25 kgR W Maitta, L V Vasovic, K Mohandas, et al.Transfusion|March 1, 1995
Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study GroupA Shapiro, T Abe, L M Aledort, et al.European Journal of Pediatrics|September 1, 1993
Squamous-cell carcinoma arising in a non-irradiated child with recurrent respiratory papillomatosisB Simma, R Burger, J Uehlinger, et al.Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Extracorporeal model for study of factors affecting thrombus formationA M Benis, H L Nossel, L M Aledort, et al.Pageof 11